Video: “Metastatic Castration-Sensitive Prostate Cancer (mCSPC) Treatment Intensification”

Home » Video: “Metastatic Castration-Sensitive Prostate Cancer (mCSPC) Treatment Intensification”

Mar. 2026 Awareness Night

Metastatic Castration-Sensitive Prostate Cancer (mCSPC)  Treatment Intensification
A Patient’s Guide to Choosing with Confidence

Dr. Urban Emmenegger MD
Medical Oncologist, Odette Cancer Centre (Division of Medical Oncology)
Associate Scientist, Sunnybrook Research Institute (Biological Sciences Platform)
Associate Member, Institute of Medical Science, University of Toronto

 

 

Presentation Overview:

  • Pros and cons of treatment intensification (hormone therapy alone vs. adding androgen receptor inhibitors, chemotherapy, or other intensification strategies).
  • Key decision factors: survival benefit, quality of life, travel/monitoring needs, cost/insurance considerations, and personal priorities.
  • How doctors weigh disease features (tumor volume, symptoms, PSA, scans) and patient factors (age, comorbidities [medical conditions], values).

CLICK ON THE ARROW TO START THE VIDEO

The Complete Presentation time is 1:49:05
Disclaimer:  The contents of this video is solely for the purposes of education and information and does not constitute personal diagnostic advice or personal medical advice.

 

Scroll to Top